We are thrilled to highlight the launch of Slow Release—a dedicated series hosted by TranslationsInLondon in partnership with GRC Health. Designed specifically for pharmaceutical teams, CROs, and life sciences regulatory professionals, Slow Release breaks down the crucial mechanics of high-stakes healthcare translation, cognitive debriefing, and cultural adaptation.

Below is a recap of our first two foundational episodes, including links to watch, listen, and read the full deep-dives.


Episode 1: Cognitive Debriefing 101 – Proving a Translated Questionnaire Landed

Featured Guest: Mark Gibson (Owner & CEO, GRC Health)
Host: Valentina Vignolo Love (Director, TranslationsInLondon)

A mistranslated clinical questionnaire is like a poorly delivered medicine—right ingredient, wrong release mechanism, so the patient never absorbs it correctly. In our launch episode, Valentina and Mark unpack cognitive debriefing—the essential interview step in linguistic validation that proves whether a translated Clinical Outcome Assessment (COA) or Patient-Reported Outcome (PRO) actually works with real patients.

Key Topics Covered:

  • What Cognitive Debriefing Actually Is: Where it fits into the ISPOR-compliant linguistic validation workflow.
  • Cognitive Burden vs. Cognitive Fatigue: Identifying the subtle signs that a patient is struggling with confusing phrasing.
  • Real-World Case Study: Testing a 450-item smoking cessation diary in 4.5-hour patient interviews.
  • Regulatory Expectations: What the FDA and EMA expect to see documented from a debriefing round before accepting submission data.

Episode 2: Linguistic Validation & The Human Factor in Patient Research

Featured Guests: Mark Gibson (GRC Health) & Nur Ferrante (Art of Diversity)
Host: Valentina Vignolo Love (Director, TranslationsInLondon)

Following up on our introduction to cognitive debriefing, Episode 2 dives into why treating patient questionnaires as "standard copy translation" risks clinical trial data integrity. Mark, Nur, and Valentina strip away the corporate veneer to explain why standard translation processes fail in clinical trials and how interviewer soft skills protect patient trust.

Key Topics Covered:

  • Beyond Word-for-Word: Why treating Clinical Outcome Assessments (COAs) like ordinary copy damages endpoint data quality.
  • Who Runs Cognitive Debriefing? The critical skill gap between standard translation and specialized patient research.
  • Attunement & Cultural Sensitivity: Navigating patient cognitive burden, compassion, and taboos without prompting bias.
  • The Ripple Effect: How rigorous linguistic validation skills extend to usability testing, brand naming, and pharmacovigilance.


What’s Next for Slow Release?

New episodes drop regularly! We will continue bringing together experts from across life sciences, localization, and regulatory compliance to address the industry’s most pressing communication challenges.

Have a question about linguistic validation for your upcoming trial?
📩 Explore TIL's Linguistic Validation Services or Contact the TranslationsInLondon Team.